January 4, 2018 / 11:20 AM / 9 months ago

Sanofi says will work with Manila in spite of Dengvaxia ban

PARIS (Reuters) - France’s Sanofi (SASY.PA) said on Thursday it would continue to cooperate with the Philippines’ Food and Drug Administration after the country suspended clearance for its controversial dengue vaccine Dengvaxia.

FILE PHOTO: French multinational pharmaceutical company SANOFI logo seen at their headquaters in Paris, France, March 8, 2016. REUTERS/Philippe Wojazer/File Photo

The Philippines government also fined Sanofi a symbolic $2,000 (£1,476.30) Health Secretary Francisco Duque told Reuters.

“Sanofi Pasteur confirms that in accordance with international and local laws, regulations and company standards, post-approval commitments for Dengvaxia, as described in the pharmacovigilance plan submitted to the Philippines FDA and other national regulatory authorities, have been – and will continue to be – fulfilled,” a Sanofi spokesman said.

Reporting by Matthias Blamont; Editing by Geert De Clercq

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below